Nadofaragene firadenovec, sold under the brand name adstiladrin, is a gene therapy for the treatment of bladder cancer This medicine is to be used only by or under the direct supervision of a doctor. It delivers a copy of the gene encoding ifnα2b to the bladder urothelium resulting in local expression of the ifnα2b protein for anti. Adstiladrin is a localized gene therapy designed to help the immune system fight nmibc directly within the bladder
WATCH
